Moderna surges on S&P 500 inclusion

Moderna jumped to a fresh record after S&P Dow Jones Indices said late on Thursday it plans to add the firm to its benchmark index. The Covid-19 vaccine maker rallied as much as 11% to $288.88 on Friday as the company will replace Alexion Pharmaceuticals in the S&P 500 Index.